Interleukin (IL) 18, a powerful inducer of the immunoregulatory cytokine interferon-g (IFN-g), presents upstream of the cytokine activation cascade in the inflammatory response. The anti-inflammatory properties of steroids permit their use in various conditions, although effects are transient and pathological states are not fully relieved by short-term steroidal use. We examined the effect of lipopolysaccharide (LPS)/IL-2 on the cytokine cascade in human peripheral blood mononuclear cells (PBMCs). We also examined the effect of steroids on LPS/IL-2-induced cytokine production in human PBMCs taken from healthy volunteers. Cell-free supernatant fractions were assayed for IL-18, IL-12, IL-2, IFN-g and IL-10 protein, using enzymelinked immunosorbent assays, and synergy between LPS and IL-2 in enhanced production of IL-18 was observed. Steroids suppressed the production of IL-18 and other secondary cytokines in LPS/IL-2-stimulated PBMCs, in a concentration-and timedependent manner, although inhibition was incomplete even at high concentrations. Effects of steroid treatment on expression of membrane-bound LPS receptor antigen (mCD14) and intercellular adhesion molecule-1 (ICAM-1) in PBMCs were studied by flow cytometric analysis. Steroid treatment up-regulated mCD14 expression in a concentration-dependent manner, with no effect on ICAM-1 expression. These results suggest that the incomplete counteraction of steroids in the LPS/IL-2-initiating cytokine cascade is due, at least partly, to the up-regulation of mCD14 by steroid preparations, which increases susceptibility to bacterial endotoxins.
Introduction
Steroid hormones have profound antiinflammatory actions and are central in the clinical therapy of inflammatory and autoimmune diseases, affecting humoral and cell-mediated immunity. 1 Steroids are likely to exert anti-inflammatory effects through many mechanisms. 2 High-affinity steroid receptors have been identified in monocytes/macrophages, 3 and during steroid administration in vivo, an alteration of monocyte kinetics in M Kodama, HK Takahashi, H Iwagaki et al.
Steroid effects in PBMCs peripheral blood occurs, causing monocytopenia and failure to accumulate at inflammatory sites. 4, 5 Steroids also induce functional changes in monocytes/macrophages, such as diminished chemotaxis 6 and antimicrobial activity, 7 and alter the secretion of proteinases, including collagenase and plasminogen activator. 8, 9 Steroids also suppress the production of interleukin (IL)-1 and tumour necrosis factor (TNF), which are both monocyte/ macrophage-derived cytokines that mediate inflammatory reactions. 10, 11 Several effects of steroids on monocyte/ macrophage antigen (Ag) cell surface expression have been reported; steroids diminish receptor activity for immunoglobulin (Ig) G and complement C3, 12 and induce the low-density lipoprotein receptor, 13 MHC class II Ag 14 and other membrane Ags. 15 -17 Another important monocyte cell surface molecule 18 involved in endotoxininduced monocyte activation is the glycosylphosphatidylinositol-anchored CD14 Ag, which acts as a receptor for lipopolysaccharide (LPS) or complexes of LPS/LPS-binding protein (LBP). 19, 20 Soluble CD14 (sCD14) is released from CD14expressing cells in culture supernatants 21 and body fluids, 22 and serum concentrations of sCD14 are elevated under pathological conditions where monocyte activation occurs, such as septicaemia and infection. 23, 24 Both sCD14 and membranebound CD14 (mCD14) Ag are involved in cellular activation via endotoxins, 25 and mCD14 is regulated by several factors including IL-4 26 and interferon-γ (IFN-γ). 27 LPS can also induce mCD14 and sCD14 in peripheral blood monocytes. 28, 29 Interleukin 18 was first characterized as an IFN-γ-inducing factor in the blood of mice primed with Propionibacterium acnes and stimulated with LPS. 30 Secreted from LPSactivated monocytes/macrophages and many other cells, 31 -34 IL-18 may be involved in many pathological conditions including the host defence against fungal and bacterial infection, 35, 36 autoimmune diabetes, 37 P. acnes-primed LPS-induced hepatitis, 38 autoimmune encephalomyelitis, 39 primary biliary atresia 40 and alloresponsiveness in mixed lymphocyte reactions. 41 Immunosuppressive steroid treatment is indispensable in these acute cases, in which immunopathological processes may bring about serious organ injury. Clinical observations, however, demonstrate that steroid pulse therapy does not fully counteract acute syndromes, and mechanisms of action remain unclear.
We have demonstrated in vitro that IL-18 is present upstream of the cytokine activation cascade in inflammatory or immune responses. 41 -43 In the present study, we demonstrate synergy between LPS and IL-2 in enhanced production of IL-18 in cultured peripheral blood mononuclear cells (PBMCs), and the effect of steroids on IL-18 and other LPS/IL-2-initiating cytokine production. We used flow cytometry to analyse expression of mCD14 on PBMCs because the inhibitory effects of steroids on LPS/IL-2-initiated cytokine production were incomplete even at high concentrations.
Materials and methods

REAGENTS AND DRUGS
The following reagents were purchased: recombinant human IL-18 and anti-IL-18 monoclonal antibodies (mAb) (Medical & Biological Laboratories, Nagoya, Japan); IL-2 (R&D Systems, Minneapolis, USA); anti-IL-12 mAb and anti-IL-2 mAb (PharMingen, San Diego, USA); LPS (Sigma, St Louis, USA). Steroids (methyl prednisolone sodium succinate [MPSS] and hydrocortisone sodium succinate [HSS]) were donated by Pharmacia & Upjohn (Tokyo, Japan). For flow cytometric analysis, we purchased fluorescein isothiocyanate (FITC)-conjugated murine IgG1 mAb against ICAM-1, which is an anti-CD54 mAb, 6.5B5, that recognizes the D1 domain (DAKO, Glostrup, Denmark); FITC-conjugated MOPC 21, an IgG1 class-matched control (Sigma, St Louis, USA) and phycoerythrin (PE)conjugated anti-CD14 (monocytes) mAb (DAKO, Glostrup, Denmark).
PBMC ISOLATION AND CULTURE
Normal human PBMCs were obtained from 10 healthy volunteers who gave oral informed consent. Between 20 and 50 ml peripheral blood was withdrawn from each volunteer's forearm vein. The PBMCs were isolated by centrifugation on a density gradient of Ficoll-Paque (Pharmacia, Uppsala, Sweden); washed three times in Rosen Park Memorial Institute (RPMI) 1640 medium (Nissui, Tokyo, Japan) supplemented with 10% (v/v) heat-inactivated fetal calf serum (FCS), 20 µg/ml kanamycin, and 100 µg/ml streptomycin and penicillin (Sigma, St Louis, USA); and suspended at a final concentration of 1 × 10 6 cells/ml in RPMI 1640 medium supplemented with 10% (v/v) heat-inactivated FCS.
CYTOKINE ASSAYS
The PBMCs (1 × 10 6 cells/ml) were incubated with LPS, IL-2 and IL-18 for 0 -48 h at 37°C in a humidified atmosphere of 5% CO 2 in air, and all reagents were added to the media at the start of incubation. After culture, cell suspensions were transferred into Eppendorf tubes and centrifuged. Cell-free supernatant fractions were assayed using enzyme-linked immunosorbent assays (ELISAs) employing the multiple antibodies (Ab) sandwich principle (for IL-18, MBL; for other cytokines, Quantikine™, R&D Systems, Minneapolis, USA) and detection limits for IL-18, IL-12, IL-10 and IFN-γ were 10 pg/ml. When the effect of steroids (MPSS/HSS) and mAbs (anti-IL-18/IL-12/IL-2) was examined, these were added to the culture media at the start of incubation with LPS (100 ng/ml) and IL-2 (10 IU/ml). All experiments were undertaken in triplicate, at least.
FLOW CYTOMETRIC ANALYSIS
The PBMCs (1 × 10 6 cells/ml) were cultured at 37°C in a 5% CO 2 /air mixture under the conditions described above. Culture cells (5 × 10 5 cells/sample) were washed once with washing buffer (phosphate-buffered saline supplemented with 2.5% normal horse serum, 0.1% NaN 3 and 0.01 M hepes, pH 7.3). Cells were then incubated with 1 µg FITC-conjugated anti-ICAM-1 Ab or PE-conjugated anti-CD14 Ab for 20 min at 4°C. After washing, cells were fixed with 2% paraformaldehyde and analysed with a FACS Calibur ™ (Becton Dickinson, CA, USA). Data were processed using the CELL QUEST ™ program (Becton Dickinson, CA, USA) and expressed as the relative fluorescent intensity against class-matched controls (MOPC 21). The results are the means ± SE of three donors.
STATISTICAL ANALYSIS
Statistical significance was evaluated using ANOVA followed by the Student's two-tailed t-test. P < 0.05 was considered statistically significant.
Results
EFFECT OF LPS/IL-2 ON IL-18 PRODUCTION
When PBMCs were cultured for 24 h with LPS (0 -1000 ng/ml) plus IL-2 (0 -100 IU/ml), IL-18 release increased in a concentration-dependent manner and synergy between LPS and IL-2 was observed for IL-18 production ( Fig. 1 ).
KINETICS OF LPS/IL-2-INDUCED IL-18 PRODUCTION
When PBMCs were stimulated with LPS (100 ng/ml) and IL-2 (10 IU/ml), IL-18 production was detected at 4 h, reached near at 24 h and decreasing thereafter. No differences in the production of IL-10 were observed between LPS/ IL-2-stimulated andunstimulated PBMCs (Fig. 4 ).
EFFECT OF STEROIDS ON LPS/IL-2-INDUCED CYTOKINE PRODUCTION
The PBMCs were cultured for 24 h with LPS (100 ng/ml), IL-2 (10 IU/ml) and MPSS or HSS with a concentration range of 0 -1000 pg/ml. Both steroids suppressed LPS/IL-2-stimulated IL-18, IL-12, IFN-γ and IL-10 production in human PBMCs in a dose-dependent manner. Steroid concentrations ≥ 100 pg/ml inhibited IL-18, IL-12, IFN-γ and IL-10 production significantly (P < 0.05), although suppressive effects were incomplete even at 1000 pg/ml concentrations ( Fig. 5 ).
EFFECT OF IL-18 ON CYTOKINE PRODUCTION
Interleukin 12 and IFN-γ released from PBMCs were incubated with IL-18 for 24 h. Over this maximal levels at 24 h and decreased thereafter. No IL-18 production was observed in unstimulated PBMCs (Fig. 2 ).
EFFECT OF LPS/IL-2 ON IL-12, IFN-g AND IL-10 PRODUCTION
Interleukin 12 and IFN-γ release was concentration-dependent and synergy between LPS and IL-2 was observed when PBMCs were cultured for 24 h with LPS (0 -1000 ng/ml) and IL-2 (0 -100 IU/ml). In contrast, IL-10 production during this culture period showed no concentration dependency ( Fig. 3 ).
KINETICS OF LPS/IL-2-INDUCED IL-12, IFN-g AND IL-10 PRODUCTION
Interleukin 12 and IFN-γ production increased significantly in PBMCs cultured with LPS (100 ng/ml) and IL-2 (10 IU/ml), compared with levels in unstimulated PBMCs during the culture period (P < 0.05). At 4 h and 12 h, respectively, IL-12 and IFN-γ production was detected, reaching near maximal levels period, there was a concentration-dependent inhibition of IL-2 and IL-10 production by IL-18. Effects of IL-18 on IFN-γ and IL-10 production were most noticeable in IL-18 concentrations ≥ 1 ng/ml ( Fig. 6 ).
KINETICS OF IL-18-INDUCED CYTOKINE PRODUCTION
The production of IL-12 and IFN-γ in PBMCs cultured with IL-18 (100 ng/ml) increased significantly compared with levels in unstimulated PBMCs during the culture period. IL-12 production was detected at 4 h, reached near maximum levels at 24 h and decreased thereafter. At 4 h IFN-γ production was detected and then increased throughout the culture period, whereas IL-2 and IL-10 production in IL-18-stimulated PBMCs decreased significantly compared with levels in unstimulated PBMCs (Fig. 7) .
EFFECT OF MPSS/HSS ON IL-18-INDUCED CYTOKINE PRODUCTION
The PBMCs were cultured for 24 h with IL-18 (100 ng/ml), in the presence of MPSS and/or HSS at 0 -1000 pg/ml concentrations. Both steroids inhibited IL-18-induced IL-12, IL-2, IFN-γ and IL-10 production in a concentrationdependent manner. At the highest concentration, steroids suppressed IL-18-induced cytokine production completely ( Fig. 8 ).
EFFECT OF VARIOUS CYTOKINE ANTIBODIES ON CYTOKINE RESPONSES TO LPS/IL-2
To investigate cytokine interactions in LPS/IL-2-stimulated PBMCs, we examined the effects of the treatments anti(α)-IL-18 Ab (10 ng/ml), α-IL-12 Ab (10 ng/ml), α-IL-2 Ab (10 ng/ml) on IL-18, IL-12, IFN-γ and IL-10 production at 24 h. Adding α-IL-18 Ab, reduced IL-10 production significantly (P < 0.05). Treatment of α-IL-12 Ab, α-IL-2 Ab and α-IL-12 Ab/α-IL-2 Ab had no significant effects on IL-10 production in LPS/IL-2stimulated PBMCs (Fig. 9 ).
EFFECTS OF STEROIDS ON CD14 OR ICAM-1 EXPRESSION
The PBMCs were incubated in MPSS or HSS for 24 h, and both hormones up-regulated CD14 expression in PBMCs dose-dependently, whereas ICAM-1 expression was not influenced at any steroid concentration ( Fig. 10 ).
Discussion
Accumulating evidence indicates that inflammatory stimuli and microbial products induce the production of numerous mediators which interact in a complex manner. Exposure to endotoxin (LPS) during Gram-negative sepsis results in the release of various cytokines, and cells that release these mediators include monocytes/macrophages and granulocytes. Two proteins are of principal importance in stimulation of these myeloid cells: LBP, a plasma protein 44, 45 and CD14, a monocyte/macrophage and granulocyte membrane protein. 46 LBP is a 60-kDa glycoprotein found in normal human serum which binds to LPS via the lipid A moiety, 47 whereas CD14 is a 55-kDa glycoprotein anchored to the monocyte/macrophage membrane via glycerophosphatidylinositol. 48 mCD14 is a receptor for LPS and LBP complexes, 49 and evidence indicates that the LBP/CD14dependent pathway contributes to monocyte/macrophage and granulocyte stimulation by LPS. sCD14, which lacks the glycerophosphatidylinositol anchor, is also present in serum although its origin and function are not fully defined. 50 A novel, IL-12-independent IFN-γinducing cytokine, which has been cloned and renamed IL-18, is synthesized by hepatic macrophages (Kupffer cells) in mice pre-conditioned with P. acnes. 30 Reports suggest that IL-18 is involved in many pathological conditions 35 -41 and is present most often upstream of the cytokine cascade in inflammatory or immune responses. 41 -43 Our present research demonstrates that LPS and IL-2 synergistically induce IL-18 production, as well as IL-12 and IFN-γ production, in human PBMCs (Figs 1 -4) . This in vitro model could be used to study disease associations, or in clinical settings. The pattern of IL-18-induced effects on cytokine production was identical to that of LPS/IL-2 in IL-12 and IFN-γ production, suggesting that the activation cascade after IL-12 production is common to both stimuli although the pattern of IL-10 production differs between these stimuli (Figs 2 and 6) .
Interleukin 12 is believed to be an important initiator of cellular immune responses. Production of IL-12 by monocytes/ macrophages is pathogen-induced and upregulated by means of a feedback mechanism through IFN-γ, which, in turn, stimulates IL-12 production by monocytes/ macrophages. 51 The positive feedback mechanism via IFN-γ supports an ongoing immune response, which would cease if the pathogen-induced IL-12 production by monocytes/macrophages is cleared. 52 Whether this is an adequate regulatory mechanism or whether additional negative regulators of IL-12-induced immune responses may control cell-mediated immune responses is unclear.
Interleukin 10 is an important negative regulator of T-cell responses that is produced by T cells, monocytes/macrophages and B cells, 53 and inhibits T-cell proliferation and cytokine production. 54 -56 IL-10 exerts negative effects on T cells mainly through the Ag-presenting cells, 57, 58 although a minor effect on T cells has been described. 59 Through down-regulation of MHC class II 60 and CD80 61 expression on monocytes/ macrophages, IL-10 interferes with T-cell activation.
The present research demonstrated that IFN-γ production increased whereas IL-10 production decreased concentration-dependently in IL-18-stimulated PBMCs. Our findings are consistent with reports that IFN-γ strongly inhibits IL-10 production in PBMCs. 53 -56 Conversely, in LPS/IL-2-stimulated PBMCs, IFN-γ production increased concentration-dependently, as well as in the IL-18-initiated cytokine cascade, although IL-10 production did not decrease in this manner. IFN-γ did not inhibit IL-10 production in LPS/IL-2-stimulated PBMCs, which resulted in continuous production of IL-18/IL-12. Both cytokines are among the most important endogenous stimulators of IFN-γ secretion from natural killer and T cells, therefore IL-10 production continued to inhibit IFN-γ production. It is tempting to postulate that IL-10 is a negative regulator of IL-18/IL-12-induced IFN-γ production, a hypothesis which is consistent with reports that IL-12 induces T cells to produce IL-10, suggesting that IL-12-induced IL-10 production by T cells functions as a negative feedback for IL-12-induced immune responses. 62 The present research also showed that steroid hormones inhibit LPS/IL-2-initiated cytokine production, although their effects on IL-18, IL-12, IFN-γ and IL-10 production were incomplete even at high concentrations (Fig. 5 ). This finding was consistent with experiences that effects of steroid therapy in inflammatory or autoimmune diseases are usually transient and incomplete. In contrast, the inhibitory effects of steroids on IL-12, IL-2, IFN-γ and IL-10 production in the IL-18-induced cytokine cascade were complete (Fig. 8 ). Our findings also showed Ab against IL-18/IL-12/IFN-γ as useful regulators of the LPS/IL-2-induced cytokine response ( Fig. 9) : α-IL-18 Ab and α-IL-12 Ab completely inhibited IL-18 and IL-12 production, respectively, in LPS/IL-2stimulated PBMCs. The α-IL-18/α-IL-12/ α-IL-2 Ab combination completely suppressed IFN-γ production in the LPS/IL-2initiating cytokine cascade. The cytokine Ab treatment described above is therefore a promising modality for inflammatory or autoimmune diseases that cannot be controlled by steroid therapy alone.
Our findings also demonstrated that the continuous presence of steroids increased mCD14 expression in PBMCs concentrationdependently. In contrast, steroid exposure did not enhance ICAM-1 expression ( Fig. 10 ). mCD14 is a receptor for complexes of LPS and LBP, and the LPS/CD14-dependent pathway contributes to monocyte/ macrophage stimulation by LPS. 49 A positive correlation between the LPS-binding capacity and the amount of mCD14 expressed on human blood monocytes/ macrophages has been described; 63 therefore, our results suggest that continuous steroid exposure would increase susceptibility to bacterial endotoxins under given conditions. Our research also showed that steroid treatments cannot completely suppress LPS/IL-2-induced cytokine production, even at higher concentrations. The reason for this can partly be ascribed to steroid-induced up-regulation of mCD14, which may contribute to the increased risk of persistent and uncontrolled inflammation in patients on steroid therapy with sepsis. Therefore, continuous use of steroids in infectious diseases to suppress systemic inflammatory response syndrome 64 should be undertaken cautiously, especially when bacterial endotoxins are not totally cleared.
In one report, mCD14 expression by human monocytes/macrophages was shown to decrease in patients with acute inflammatory diseases receiving glucocorticoid pulse therapy in a time-and concentrationdependent manner, 65 which contradicts our present results. CD14 triggers the production of inflammatory cytokines, including TNF and IL-1, by activated monocytes/macrophages, and also participates in the monocyte/macrophage-dependent T-cell proliferation after antigenic stimulus. 66, 67 In our present research, the concentrationdependent effect of steroid preparations on mCD14 expression in human PBMCs, including T cells and monocytes/macrophages, was examined. The contradictory results found in the steroidal effects was partly ascribed to T-cell-monocyte/macrophage interactions. A recent report demonstrated that the continuous presence of dexamethasone in granulocyte macrophage colony-stimulating factor/IL-4-induced monocyte-derived dendritic cell cultures made the cells immature with increased CD14 expression, 68 which is consistent with our findings. Further research investigating effects of steroid preparations on mCD14 expression and mechanisms is warranted.
Immunosuppressive treatment with steroids is indispensable in cases of acute syndromes in which immunopathological processes could result in serious organ injury. However, our present findings demonstrate that steroids do not completely suppress the LPS/IL-2-initiating cytokine cascade by human PBMCs, partly because of steroidinduced up-regulation of mCD14. These findings support the idea of an impaired immune response to endotoxin stimulus in monocytes/macrophages during steroid application. Since CD14 is characterized as an endotoxin receptor, inappropriate expression of CD14 may lead to a dysregulatory immune response towards bacterial infections. Thus, the up-regulatory action of steroid preparations on the LPS receptor CD14 may impair the control of Ag-presenting cells to defend against infectious agents. Therefore, steroid therapy to suppress excessive inflammatory response syndrome in bacterial insults should be used cautiously. Our current findings also demonstrate that the α-IL-18 Ab/α-IL-12 Ab/ α-IL-2 Ab combination inhibits LPS/IL-2stimulated cytokine production completely, suggesting these Abs are useful regulators of excessive immunoresponse. 
